Prim, S.A. (BME:PRM)
Spain · Delayed Price · Currency is EUR 13.15
+0.15 (1.15%)
May 18, 2026, 2:49 PM CET
Prim, S.A. Market Cap
Prim, S.A. has a market cap or net worth of €221.18 million as of May 18, 2026. Its market cap has increased by 22.07% in one year.
Market Cap
221.18M
Enterprise Value
213.62M
Revenue
251.89M
Ranking
n/a
PE Ratio
13.27
Stock Price
€13.15
Market Cap Chart
Since March 2, 1998, Prim, S.A.'s market cap has increased from 7.51M to 221.18M, an increase of 2,846.56%. That is a compound annual growth rate of 12.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 221.18M | -1.53% |
| Dec 31, 2025 | 224.61M | 37.21% |
| Dec 31, 2024 | 163.70M | -7.91% |
| Dec 29, 2023 | 177.76M | -3.62% |
| Dec 30, 2022 | 184.45M | -26.55% |
| Dec 30, 2021 | 251.13M | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.42B |
| Laboratorios Farmaceuticos Rovi | 3.04B |
| Almirall | 2.47B |
| Pharma Mar | 1.69B |
| Clínica Baviera | 884.22M |
| Laboratorio Reig Jofre | 218.18M |
| Oryzon Genomics | 218.12M |
| Atrys Health | 207.22M |